Black cancer patients better represented in publicly-funded clinical trials

Black patients are better represented in taxpayer-funded clinical trials testing new cancer treatments compared to trials run by pharmaceutical companies – although black patients are not fully represented in cancer clinical trials, regardless of sponsor.